These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 14967806)

  • 41. Validation of a nomogram to predict the presence of sentinel lymph node metastases in melanoma.
    Piñero A; Canteras M; Ortiz E; Martínez-Barba E; Parrilla P
    Ann Surg Oncol; 2008 Oct; 15(10):2874-7. PubMed ID: 18648880
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Analysis of lymph mode recurrence in patients with melanoma and negative sentinel lymph node negative. Retrospective study at the Hospital Saint-Louis, Paris].
    Derhy Y; Kerob D; Verola O; Binder JP; Lebbe C; Revol M; Servant JM
    Ann Chir Plast Esthet; 2005 Apr; 50(2):104-12. PubMed ID: 15820595
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Failure to identify the sentinel lymph node for cutaneous melanoma--significant prognostic and management implications.
    Moncrieff M; Herbert J; Hancock K; Green AR
    Br J Plast Surg; 2005 Jul; 58(5):753-5. PubMed ID: 15992535
    [No Abstract]   [Full Text] [Related]  

  • 44. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
    Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
    Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MCW melanoma cocktail for the evaluation of micrometastases in sentinel lymph nodes of cutaneous melanoma.
    Shidham VB; Chang CC; Komorowski R
    Expert Rev Mol Diagn; 2005 May; 5(3):281-90. PubMed ID: 15934808
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The value of sentinel lymph node biopsy in the management of head and neck melanoma.
    Alvarado M; Sondak V; Leong PL
    J Surg Oncol; 2007 May; 95(6):524-5; author reply 523. PubMed ID: 17221851
    [No Abstract]   [Full Text] [Related]  

  • 47. Utility of computed tomography and magnetic resonance imaging staging before completion lymphadenectomy in sentinel lymph node-positive melanoma.
    Miranda EP
    J Clin Oncol; 2006 Nov; 24(32):5178; author reply 5178. PubMed ID: 17093288
    [No Abstract]   [Full Text] [Related]  

  • 48. Analysis of lymph nodal metastases in malignant melanoma using the poisson probability paradigm and Bayes rule.
    Vollmer RT
    Am J Clin Pathol; 2005 May; 123(5):707-15. PubMed ID: 15981810
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sentinel node identification by scintigraphic methods in cutaneous melanoma.
    Dias Moreira R; Altino de Almeida S; Maliska Guimarães CM; Resende JF; Gutfilen B; Barbosa da Fonseca LM
    J Exp Clin Cancer Res; 2005 Jun; 24(2):181-5. PubMed ID: 16110749
    [TBL] [Abstract][Full Text] [Related]  

  • 50. What good is sentinel lymph node biopsy for melanoma if it does not improve survival?
    McMasters KM
    Ann Surg Oncol; 2004 Sep; 11(9):810-2. PubMed ID: 15313736
    [No Abstract]   [Full Text] [Related]  

  • 51. [Distinguishing nodal naevus from melanoma metastases in the sentinel node in patients with melanoma].
    Witte ME; Gerrits EG; Klaase JM; Mastboom WJ; Sterk LM
    Ned Tijdschr Geneeskd; 2006 May; 150(19):1072-6. PubMed ID: 16733984
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tumour regression does not increase the risk of sentinel node involvement in thin melanomas.
    Cecchi R; Pavesi M; Buralli L; Innocenti S; De Gaudio C
    Chir Ital; 2008; 60(2):257-60. PubMed ID: 18689175
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Freedom of expression or protectionism in the debate on sentinel node biopsy in melanoma.
    Thomas JM
    J Am Acad Dermatol; 2009 Dec; 61(6):1079. PubMed ID: 19925932
    [No Abstract]   [Full Text] [Related]  

  • 54. Isolated tumor cells and long-term prognosis of patients with melanoma.
    van Akkooi AC; de Wilt JH; Verhoef C; Eggermont AM
    Ann Surg Oncol; 2008 May; 15(5):1547-8. PubMed ID: 18197454
    [No Abstract]   [Full Text] [Related]  

  • 55. The chances of a patient with melanoma developing in transit disease are doubled by undergoing sentinel lymph node biopsy (SLNB).
    Russell-Jones R; Powell AM; Acland K; Calonje E; O'Doherty M; Healy C
    Eur J Surg Oncol; 2005 Mar; 31(2):210-1. PubMed ID: 15698741
    [No Abstract]   [Full Text] [Related]  

  • 56. Lymphangiogenesis: host and tumor factors in nodal metastasis.
    Sondak VK; Messina JL
    Arch Dermatol; 2008 Apr; 144(4):536-7. PubMed ID: 18427050
    [No Abstract]   [Full Text] [Related]  

  • 57. Tattoo pigment in two lymph nodes in a patient with melanoma.
    Dominguez E; Alegre V; García-Melgares ML; Laguna C; Martín B; Sánchez JL; Oliver V
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):101-2. PubMed ID: 18181980
    [No Abstract]   [Full Text] [Related]  

  • 58. Impact of false-negative sentinel lymph node biopsy on survival in patients with cutaneous melanoma.
    Caracò C; Marone U; Celentano E; Botti G; Mozzillo N
    Ann Surg Oncol; 2007 Sep; 14(9):2662-7. PubMed ID: 17597345
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma.
    Paek SC; Griffith KA; Johnson TM; Sondak VK; Wong SL; Chang AE; Cimmino VM; Lowe L; Bradford CR; Rees RS; Sabel MS
    Cancer; 2007 Jan; 109(1):100-8. PubMed ID: 17146784
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The atypical Spitz tumor of uncertain biologic potential: a series of 67 patients from a single institution.
    Urso C
    Cancer; 2010 Jan; 116(1):258; author reply 258-9. PubMed ID: 19862819
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.